5-[(14-amino-3,6,9,12-tetraoxatetradecan-1-yl)oxy]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione hydrochloride
Structure Info
- Chemspace ID
- CSSB06256033950 (In-Stock Building Blocks)
- CAS
- 2703775-06-6, 2797619-65-7
- MFCD
- MFCD34550803
- IUPAC Name
- 5-[(14-amino-3,6,9,12-tetraoxatetradecan-1-yl)oxy]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione hydrochloride
- Mol formula
- C23H32ClN3O9
- Mol weight
- 530 Da
- Catalog Number(s)
- AA02508J, AD255654, AG0250BB, AR02510B, ArZ-UP355017, BD01417848, BJ92719, EN300-36596307, HTS065454, HY-138784A, TX0251GZ, Y3164119, Z5243348639, ZXC247837
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -1.13
- Heavy atoms count
- 36
- Rotatable bond count
- 16
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.565
- Polar surface area (Å)
- 156
- Hydrogen bond acceptors count
- 10
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB06256033950
Items Overall 30 items from 8 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine US, Inc. | 2 days | United States To: | 95 | 100 mg | 888.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 250 mg | 1,265.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 500 mg | 1,995.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 1 g | 2,558.00 | |
| Enamine US, Inc. | 2 days | United States To: | 95 | 2.5 g | 5,014.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 95 | 5 mg | 265.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 95 | 25 mg | 870.00 | |
| Advanced ChemBlocks CN | 10 days | China To: | 95 | 100 mg | 2,240.00 | |
Description: 1H-Isoindole-1,3(2H)-dione, 5-[(14-amino-3,6,9,12-tetraoxatetradec-1-yl)oxy]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride; CAS: 2703775-06-6 | ||||||
| Angene International Limited | 10 days | China To: | 95 | 25 mg | 540.90 | |
| Angene International Limited | 10 days | China To: | 95 | 50 mg | 857.70 | |
| Angene International Limited | 10 days | China To: | 95 | 100 mg | 1,391.40 | |
Description: 5-[(14-amino-3,6,9,12-tetraoxatetradecan-1-yl)oxy]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione hydrochloride; CAS: 2703775-06-6 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 124.20 | |
| A2B Chem | 12 days | United States To: | 98 | 10 mg | 172.50 | |
| A2B Chem | 12 days | United States To: | 98 | 250 mg | 2,611.65 | |
| A2B Chem | 12 days | United States To: | 98 | 500 mg | 4,077.90 | |
| A2B Chem | 12 days | United States To: | 98 | 1 g | 5,209.50 | |
| A2B Chem | 12 days | United States To: | 98 | 2.5 g | 10,151.05 | |
Description: 5-[(14-amino-3,6,9,12-tetraoxatetradecan-1-yl)oxy]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione hydrochloride; CAS: 2703775-06-6 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 25 mg | 478.40 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 50 mg | 761.30 | |
| Aaron Chemicals LLC | 12 days | United States To: | 95 | 100 mg | 1,238.55 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 888.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,265.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,995.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 2,558.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 5,014.00 | |
| eNovation CN | 20 days | China To: | 94 | 25 mg | 816.50 | |
| eNovation CN | 20 days | China To: | 94 | 50 mg | 1,259.25 | |
| eNovation CN | 20 days | China To: | 94 | 100 mg | 2,012.50 | |
Description: Thalidomide-PEG5-NH2 hydrochloride; CAS: 2703775-06-6 | ||||||
| 10X CHEM | 35 days | United States To: | 98 | 5 mg | 115.50 | |
| 10X CHEM | 35 days | United States To: | 98 | 10 mg | 162.80 | |
Description: 5-[(14-amino-3,6,9,12-tetraoxatetradecan-1-yl)oxy]-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione hydrochloride; CAS: 2703775-06-6 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire